The translation of breakthrough discoveries takes a long time from bench-to-bedside. In COVID-19 pandemic these restrictions were removed with permission of emergency use of gene therapy and recently discovered drugs in attempts to save lives. Should we do this only in crisis or seeking some safe trajectories to accelerate translational researches through reasonable regulations and rules.